Skip to main navigation

Skip to main content

FDA approves DEXTENZA^® for the treatment of ocular inflammation

About
Pipeline
Products
- DEXTENZA^®
- ReSure® Sealant
Investors
Investor Relations
Careers
- Core Values + Benefits
- Open Positions
Search

Events and Presentations

Events and Presentations

Upcoming Events

Ocular Therapeutix, Inc. at the Jefferies 2019 London Healthcare Conference 2019

Thursday, November 21, 2019 8:40 AM GMT

Click Here for Webcast

Supporting Materials

Jefferies London HC Conference Presentation 4.9 MB

Q3 2019 Ocular Therapeutix, Inc. Earnings Conference Call

Tuesday, November 12, 2019 8:00 AM EST

Click Here for Webcast

Date

Title

Jefferies London HC Conference Presentation

11/21/19

Cantor Healthcare Conference Presentation

10/4/19

Research and Discovery Day Presentation

3/28/19

Shareholder Tools

Print
E-mail
RSS
Share
Alerts
Contact

X

Share on:
Facebook
Twitter
LinkedIn
Google

Ocular Therapeutix, Inc.15 Crosby DriveBedford, MA01730Phone: 1-877-628-8998

© 2020 Ocular Therapeutix, Inc. All rights reserved. DEXTENZA and ReSure are trademarks of Ocular Therapeutix, Inc. PP-US-OTX-0004

Privacy Policy|Terms of Use

The use of this Site is governed by its Terms of Use. The information contained in this Site is for informational purposes only. It is not a substitute for professional medical advice and should not be used to diagnose or treat any medical or health condition.

The contents of this Site are subject to change without notice. Ocular Therapeutix may modify and/or discontinue operation of all or portions of this Site at any time at its sole discretion without notice, and assumes no responsibility to update this Site. Ocular Therapeutix makes no representations or warranties with respect to the use of this Site or any information obtained herein.